Discovery of an imidazopyridine-containing 1,4-benzodiazepine nonpeptide vitronectin receptor (αvβ3) antagonist with efficacy in a restenosis model
- 17 November 1998
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 8 (22) , 3171-3176
- https://doi.org/10.1016/s0960-894x(98)00556-3
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Discovery of Potent Nonpeptide Vitronectin Receptor (αVβ3) AntagonistsJournal of Medicinal Chemistry, 1997
- Cloning and Characterization of a Novel Integrin β3SubunitJournal of Biological Chemistry, 1997
- Platelet glycoprotein IIb/IIIa receptor antagonists in coronary artery diseaseEuropean Heart Journal, 1996
- Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation.Circulation, 1994
- Osteopontin-Stimulated Vascular Smooth Muscle Cell Migration Is Mediated by β3 IntegrinExperimental Cell Research, 1994
- Update on the biology and clinical study of restenosisTrends in Cardiovascular Medicine, 1994
- Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells.Circulation Research, 1994
- Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six monthsThe Lancet, 1994
- Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro.Circulation Research, 1994
- Inhibition of neointimal hyperplasia by blocking αvβ3 integrin with a small peptide antagonist GpenGRGDSPCA*Journal of Vascular Surgery, 1994